Abstract:Animals and animal models have been invaluable for our current understanding of human and animal biology, including physiology, pharmacology, biochemistry, and disease pathology. However, there are increasing concerns with continued use of animals in basic biomedical, pharmacological, and regulatory research to provide safety assessments for drugs and chemicals. There are concerns that animals do not provide sufficient information on toxicity and/or efficacy to protect the target population, so scientists are utilizing the principles of replacement, reduction, and refinement (the 3Rs) and increasing the development and application of new approach methods (NAMs). NAMs are any technology, methodology, approach, or assay used to understand the effects and mechanisms of drugs or chemicals, with specific focus on applying the 3Rs. Although progress has been made in several areas with NAMs, complete replacement of animal models with NAMs is not yet attainable. The road to NAMs requires additional development, increased use, and, for regulatory decision making, usually formal validation. Moreover, it is likely that replacement of animal models with NAMs will require multiple assays to ensure sufficient biologic coverage. The purpose of this manuscript is to provide a balanced view of the current state of the use of animal models and NAMs as approaches to development, safety, efficacy, and toxicity testing of drugs and chemicals. Animals do not provide all needed information nor do NAMs, but each can elucidate key pieces of the puzzle of human and animal biology and contribute to the goal of protecting human and animal health. Significance Statement Data from traditional animal studies have predominantly been used to inform human health safety and efficacy. Although it is unlikely that all animal studies will be able to be replaced, with the continued advancement in new approach methods (NAMs), it is possible that sometime in the future, NAMs will likely be an important component by which the discovery, efficacy, and toxicity testing of drugs and chemicals is conducted and regulatory decisions are made.

Animal-free safety assessment of chemicals: an innovation system perspective

New approach methodologies in human regulatory toxicology - Not if, but how and when!

Food for thought - Paving the way for a UK roadmap towards optimum consumer safety: Development, Endorsement and Regulatory acceptance of New Approach Methodologies (NAMs) in Chemical Risk Assessment and Beyond

A framework for chemical safety assessment incorporating new approach methodologies within REACH

Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods

Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

Consensus report on the future of animal-free systemic toxicity testing

In Silico Nanosafety Assessment Tools And Their Ecosystem-Level Integration Prospect

Public views of animal testing and alternatives in chemical risk assessment

An industry perspective on the FDA modernization act 2.0/3.0: Potential next steps for sponsors to reduce animal use in drug development

A State-of-the-Art Review on the Alternatives to Animal Testing for the Safety Assessment of Cosmetics

E-validation - Unleashing AI for validation

Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing

Upholding the EU's Commitment to ‘Animal Testing as a Last Resort' Under REACH Requires a Paradigm Shift in How We Assess Chemical Safety to Close the Gap Between Regulatory Testing and Modern Safety Science

The Implementation of the Three Rs in Regulatory Toxicity and Biosafety Assessment: The Indian Perspective

A Twin Transition in Regulatory Toxicology-moving towards Chemicals 2.0 and phasing out animal testing

The Virtual Human Platform for Safety Assessment (VHP4Safety) project: Next generation chemical safety assessment based on human data

Alternative approaches to vertebrate ecotoxicity tests in the 21st century: A review of developments over the last 2 decades and current status

Next Generation Risk Assessment approaches for advanced nanomaterials: Current status and future perspectives

Building knowledge of NAMs through risk science

The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability-A PATROLS Perspective on New Approach Methodologies